1) Aronson R, Offman HJ, Joffe RT, et al:Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch Gen Psychiatry 53:842-848, 1996
2) Bernard L, Fabio M:Pharmacogenetics of antidepressant and mood-stabilizing drug, a review of candidate-gene studies and future research directions. Int J Neuropsychopharmacol 5:255-275, 2002
3) Broom DC, Jutkiewicz EM, Rice KC, et al:Behavioral effects of δ-opioid receptor agonists:Potential antidepressants? Jpn J Pharmacol 90:1-6, 2002
4) de la Gandara J, Rojo JE, Ros S, et al:Neurophamacological basis of combining antidepressants. Acta Psychiatr Scand 112(Suppl 428):11-13, 2005
5) Grasmader K, Verwohlt PL, Rietschel M, et al:Impact of polymorphisms of cytochrome P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting. Eur J Clin Pharmacol 60:329-336, 2004
6) 橋本亮太,Chuang DM,藤巻康一郎,他:リチウムの神経保護作用.精神誌 105:81-86,2003
7) 樋口輝彦:抗うつ薬の開発動向と問題点.臨精医 33:269-273,2004
8) 井上猛,小山司:難治性うつ病の薬物療法.臨精医 29:1057-1062,2000
9) Jope RS:Lithium and GSK-3:One inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 24:441-443, 2003
10) Li X, Ketter TA, Frye MA:Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants:Are they relevant for the treatment and course of bipolar disorders? J Affect Disord 69:1-14, 2002
11) Madsen TM, Treschow A, Bengzon J, et al:Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 47:1043-1049, 2000
12) Malberg JE, Eisch AJ, Nestler EJ, et al:Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20:9104-9110, 2000
13) Ros S, Aguera L, de la Gandara J, et al:Potentiation strategies for treatment-resistant depression. Acta Psychiatr Scand 112(Suppl 428):14-24, 2005
14) Segrave R, Nathan PJ:Pindolol augmentation of selective serotonin reuptake inhibitors:Accounting for the variability of results of placebo-controlled double-blind studies in patients with major depression. Hum Psychopharmacol 20:163-174, 2005
15) Stahl SM 著,仙波純一 訳:精神薬理学エッセンシャルズ 第2版.メディカルサイエンスインターナショナル,pp131-287,2002
16) Thome J, Sakai N, Shin K, et al:cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 20:4030-4036, 2000
17) Yamada M, Yamada M, Yamazaki S, et al:Induction of cysteine string protein after chronic antidepressant treatment in rat frontal cortex. Neurosci Lett 301:183-186, 2001
18) Yamada M, Higuchi T:Functional genomics and antidepressant research, beyond the monoamine hypothesis. Eur Neuropsychopharmacol 12:235-244, 2002
19) Yamada M, Takahashi K, Tsunoda M, et al:Differential expression of VAMP2/synaptobrevin-2 after antidepressant and electroconvulsive treatment in rat frontal cortex. Pharmacogenomics J 2:377-382, 2002
20) Yamada M, Yamada M, Higuchi T:Antidepressant-elicited changes in gene expression:Remodeling of neuronal circuits as a new hypothesis for drug efficacy. Prog Neuropsychopharmacol Biol Psychiatry 29:999-1009, 2005
21) Zill P, Engel R, Baghai TC, et al:Analysis of polymorphisms in the olfactory G-protein Golf in major depression. Psychiatr Genet 12:17-22, 2002
22) Zill P, Engel R, Baghai TC, et al:Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression. Neuropsychopharmacol 26:489-493, 2002